Seonghwan Lee
Direktor/Vorstandsmitglied bei Orange Grove Bio LLC
Profil
Seonghwan Lee has current jobs as a Director at SV Investment Corp and as a Board Member at Orange Grove Bio LLC.
He has an undergraduate degree from Yonsei University and an MBA from Harvard Business School.
Aktive Positionen von Seonghwan Lee
| Unternehmen | Position | Beginn |
|---|---|---|
| SV Investment Corp/US/ | Private Equity Investor | 01.03.2020 |
Orange Grove Bio LLC
 Orange Grove Bio LLC Financial ConglomeratesFinance Orange Grove Bio LLC is a preclinical biotech company that partners with universities and entrepreneurs to develop innovative treatments for important diseases, particularly cancer and immune disorders. The company is based in Cincinnati, OH. The company fosters strong relationships with entrepreneurs and technology transfer offices outside of the traditional medical technology hubs. Orange Grove Bio's team possesses more than one hundred years of drug development and company creation experience, allowing it to build and finance innovative programs from the research and development stage to clinical trials. The company was founded by Marc Appel. Marc Appel has been the CEO since incorporation. | Direktor/Vorstandsmitglied | 01.11.2022 |
Ausbildung von Seonghwan Lee
| Yonsei University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Orange Grove Bio LLC
Orange Grove Bio LLC Financial ConglomeratesFinance Orange Grove Bio LLC is a preclinical biotech company that partners with universities and entrepreneurs to develop innovative treatments for important diseases, particularly cancer and immune disorders. The company is based in Cincinnati, OH. The company fosters strong relationships with entrepreneurs and technology transfer offices outside of the traditional medical technology hubs. Orange Grove Bio's team possesses more than one hundred years of drug development and company creation experience, allowing it to build and finance innovative programs from the research and development stage to clinical trials. The company was founded by Marc Appel. Marc Appel has been the CEO since incorporation. | Finance |
| SV Investment Corp/US/ | Finance |
